How to Find the Latest Breast Cancer Drugs: 7 Trusted Steps
How to find the latest breast cancer drugs begins with knowing your breast cancer subtype…
Articles
Top 5 Rare Disease Companies: An In-Depth Analysis of Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex
The top 5 rare disease companies include Roche, Novartis, Johnson & Johnson, AstraZeneca, and Vertex…
Abbisko’s Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT): China’s First Approved Class-1 CSF-1R Inhibitor
Abbisko’s Pimicotinib for tenosynovial giant cell tumor (TGCT) is an oral CSF-1R inhibitor developed by…
How Do Pharmaceutical Wholesalers Work? A Complete Guide to International Pharmaceutical Procurement
How do pharmaceutical wholesalers work? Pharmaceutical wholesalers source medicines from approved suppliers, manage quality control…
Antimicrobial Peptides Against Antibiotic Resistance: A Key Direction in the Global Anti-Infective Market
As antibiotic resistance continues to worsen worldwide, the pharmaceutical industry is searching for next-generation anti-infective…
Eli Lilly’s Imlunestrant Approved in China: Oral SERD Offers a New Treatment Option for ESR1-Mutated Breast Cancer
On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Eli Lilly’s innovative…
What Are the Signs of Liver Cancer Getting Worse? Symptoms of Advanced Liver Cancer
Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the…
Silevimig Approved for Rabies Passive Immunization: The First Approved Bispecific Antibody for Rabies Prevention Worldwide
On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Silevimig Injection (Jinsuxi®),…
RNA Therapeutics for Cardiovascular Disease: PCSK9, Lp(a) and Next-Gen Drug Pipeline (2026)
RNA therapeutics for cardiovascular disease are emerging as a transformative strategy for long-term disease management.…
China Approves the World’s First CAR-T Therapy for Solid Tumors: Satricabtagene Autoleucel for CLDN18.2-Positive Advanced Gastric Cancer
On June 22, 2026, China’s National Medical Products Administration (NMPA) approved Satricabtagene Autoleucel (Kailimei®), developed…